"Silmedic sp. z o.o. realizuje programy leczenia umożliwiające pacjentom dostęp do bezpłatnych, innowacyjnych metod leczenia niedostępnych na Polskim rynku. Programy te, prowadzone są przez wykwalifikowany zespół specjalistów różnych dziedzin medycyny z wieloletnim doświadczeniem. Przestrzegamy wszelkich zasad dobrej praktyki lekarskiej oraz przepisów prawa polskiego. Udział w badaniu klinicznym niesie za sobą wiele korzyści dla pacjenta : • Bezpłatna opieka wykwalifikowanych specjalistów różnych dziedzin • Dokładne monitorowanie stanu zdrowia przez cały okres leczenia • Stały i szybki kontakt ze specjalistą • Nieodpłatny dostęp do innowacyjnej metody leczenia • Możliwość nieodpłatnego wykonania szerokiego zakresu badań zleconych przez"

During the past decade, Silmedic Sp. z o.o. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Silmedic Sp. z o.o." #1 sponsor was "ACADIA Pharmaceuticals Inc." with 1 trials, followed by "Allergan" with 1 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Silmedic Sp. z o.o." #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Silmedic Sp. z o.o." are "Rheumatoid Arthritis" (2 trials), "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Silmedic Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Silmedic Sp. z o.o." are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (1 trials), "CC-99677" (1 trials), "Crisaborole Vehicle" (1 trials) and "Crisaborole ointment, 2%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Silmedic Sp. z o.o." are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Silmedic Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Silmedic Sp. z o.o., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Silmedic Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".